Freezes and reductions in National Institutes of Health funding are reverberating beyond universities and research labs to startups in the biotech industry.
This week's letter to the editor calls on US Rep. Glenn Grothman to 'acknowledge the concerns of his constituents.' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback